3173 results for «3419»

Filter By

3173 results

Severe mitral and tricuspid regurgitation

15 Dec 2022 – From GulfPCR-GIM 2022

This GulfPCR-GIM 2022 session aims to illustrate the role of mitral TEER in patients with significant MR and cardiogenic shock, to demonstrate the importance of early detection, but also to show that earlier referral and treatment of patients with significant TR is essential to prevent patients...

Severe mitral and tricuspid regurgitation

Gulf WIN - Opportunities and challenges

15 Dec 2022 – From GulfPCR-GIM 2022

Women have the floor in this special GulfPCR-GIM 2022 session: hear from members of the Gulf WIN (Women In Intervention) to better understand the status of women interventionists in the region, explore the challenges they face, and note the differences that exist with other women cardiologists...

Gulf WIN - Opportunities and challenges

Optimal management of a patient with calcified lesions - Session with LIVE case

15 Dec 2022 – From GulfPCR-GIM 2022

Watch the case of an 87-year-old male patient with DM, HTN, and hyperlipidemia, who suffered ACS six weeks ago, whose culprit lesions were treated in the RCA and LCX, and who was incidentally readmitted for LAD PCI, and find out how he was treated LIVE.

Optimal management of a patient with calcified lesions

Essential drugs that every interventionalist needs to know

15 Dec 2022 – From GulfPCR-GIM 2022

In this GulfPCR-GIM 2022 session, learn about the role of PCSK9 inhibitors in ACS and post-PCI patients, the role of SGLT2 receptor blockers and GLP RAs, and the role of P2Y12 inhibitors as unique post-PCI antiplatelet agents.

Essential drugs that every interventionalist needs to know

CABG vs. PCI - Multivessel disease

15 Dec 2022 – From GulfPCR-GIM 2022

Watch this GulfPCR-GIM 2022 session to find out more about the guidelines in revascularisation for multivessel disease, simplification of multivessel disease PCI using physiological guidance, and much more!

CABG vs. PCI - Multivessel disease

All you need to know on physiology: a 2023 update

15 Dec 2022 – From GulfPCR-GIM 2022

In this GulfPCR-GIM 2022 session, listen to William Wijns discuss the following physiology topics: long-term data on PCI deferral, update on new "negative" studies, low adoption in daily practice, and computational image-based physiology.    

All you need to know on physiology: a 2023 update

Challenging and complication cases

15 Dec 2022 – From GulfPCR-GIM 2022

Watch this GulfPCR-GIM 2022 session to learn how to deal with post-infarction ventricular rupture, an unusual post-CABG complication, a left main complication with the LACOSTE technique, the entrapment of a knotted catheter in the radial artery during primary PCI, and much more!

Challenging and complication cases

GulfPCR-GIM 2022 - Closing Ceremony

15 Dec 2022 – From GulfPCR-GIM 2022

Listen to the Course Directors thank all the participants and take stock of this 2022 edition, insisting in particular on the role of imaging, which must not however make us forget the basics of interventional cardiology, before attending the prize-giving ceremony for the best clinical cases...

GulfPCR-GIM 2022 - Closing Ceremony

Primary mitral regurgitation: treatment options when the anatomy is complex

27 Nov 2022 – From PCR London Valves 2022

Take a look at these presentations to learn more about complex primary mitral regurgitation (and how to differentiate it from simple disease), to understand why it is complex and to know what the treatment options are.

Primary mitral regurgitation: treatment options when the anatomy is complex

Repair vs. replacement for the treatment of tricuspid valve disease

27 Nov 2022 – From PCR London Valves 2022

Watch this session on tricuspid valve disease to learn more about its current modes of treatment (including new and emerging devices), to understand which patients are the best candidates for this procedure and to explore the challenges that may be encountered during it.

Repair vs. replacement for the treatment of tricuspid valve disease

TAVI: emerging evidence

27 Nov 2022 – From PCR London Valves 2022

Through the 5 abstracts of this PCR LV 2022 session, follow the comparison between last-generation balloon and self-expandable TAVR for bicuspid aortic valve stenosis, and the comparison between multiple tools to assess the risk of mortality after TAVR, evaluate the impact of post-TAVI vascular complications, and...

TAVI: emerging evidence

TAVI challenges: session 1

27 Nov 2022 – From PCR London Valves 2022

Discover a series of TAVI challenges shared by your peers: a transfemoral TAVR through a severely tortuous and horizontal aorta in a morbidly obese patient, TAVI for pure non-calcified severe aortic regurgitation in a large annulus, peripheral access calcifications and more.

TAVI challenges: session 1

TMVR challenges

27 Nov 2022 – From PCR London Valves 2022

Challenges in this session of PCR LV 2022 include hybrid valve implantation for mitral annular calcification, transcatheter double-valve implantation complicated by mitral bioprosthesis migration, and transcatheter transseptal mitral valve implantation. Watch now to find out more!

TMVR challenges

Transcatheter primary mitral regurgitation repair and tricuspid replacement - LIVE case

28 Nov 2022 – From PCR London Valves 2022

  • Part 1: Primary MR repair (recorded case)
    An 89-year-old male with atrial fibrillation, severe primary MR (prolapse A1-A2) with a preserved LV function. The operators implant 1 Pascal ACE, on general anaesthesia, guided by TEE.
  • Part 2: Tricuspid valve in valve (Live case)
    A 52-year-old female, with diabetes and...
Transcatheter intervention for mitral and tricuspid valve disease: state of the art

TRISCEND, ACURATE neo2, the LuX-Valve System: Top Late-Breaking Trials from PCR London Vaves 2022

27 Nov 2022 – From PCR London Valves 2022

Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions and learn more about the latest evidence evidence concerning new transcatheter valve devices, emerging innovative devices as well as highlighted content from the EuroIntervention journal.

Top Late-Breaking Trials

Challenging scenarios: acute coronary obstruction

28 Nov 2022 – From PCR London Valves 2022

Discover some challenging case of acute coronary obstruction in these presentations, and learn more about the anatomical and procedural factors that predict this complication during TAVI, the available strategies for coronary protection during TAVI, as well as the leaflet laceration techniques to prevent TAVI-induced coronary obstruction.

Challenging scenarios: acute coronary obstruction

CLASP II TR, TriBAND, bRIGHT: Late-Breaking Trials on tricuspid intervention

27 Nov 2022 – From PCR London Valves 2022

Discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions in this session: the CLASP II TR on transcatheter tricuspid valve repair, the TriBAND study one-year outcomes on transcatheter tricuspid annular reduction, and the bRIGHT trial on real-world outcomes for TEER.

Tricuspid - Late-Breaking Trials

Patient selection for tricuspid valve interventions

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn more about the anatomical assessment of candidates for transcatheter tricuspid valve interventions, to understand the importance of detailed haemodynamic assessment in patients with severe tricuspid regurgitation and to discuss the predictors of clinical outcome after these interventions.

Patient selection for tricuspid valve interventions

Rapid-fire abstracts: session 3

27 Nov 2022 – From PCR London Valves 2022

Everything you need to know about the OPERA-TAVI registry, the UK TAVI registry, the TAVI-COMIC study, or the external validation of the TRI-SCORE in patients undergoing isolated tricuspid valve surgery, among others, can be found in this session of PCR LV 2022.

Rapid-fire abstracts: session 3

Transcatheter mitral valve intervention is progressing more slowly than expected: why is it happening? And what can we do? Root causes, challenges and opportunities

28 Nov 2022 – From PCR London Valves 2022

Consult this session to learn about the latest news in the field of mitral valve intervention and get insights into its current slow progress, which may be caused by clinical, anatomical or technological factors.

Transcatheter mitral valve intervention is progressing more slowly than expected: why is it happening? And what can we do? Root causes, challenges and opportunities
Didn’t find what you were looking for?